Research Associate, Formulation Development (Contract)
Boost your chances before you apply.
4D Molecular Therapeutics
Emeryville, CA, US
Summary
The Research Associate will execute high-throughput formulation screening, stability studies, and formulation analytics to support biologic product development. They will also collaborate with upstream and downstream process development teams to ensure material and device compatibility.
Job Description
Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future.
4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) with a single, safe, intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration, which is currently in Phase 3 development, and second indication is diabetic macular edema. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery
GENERAL SUMMARY
4DMT is seeking a motivated Research Associate, Formulation Development (Contract) to support pre-formulation and formulation development activities for biologic products. This role reports to the Principal Scientist, Process Development. This contract role requires onsite, lab-based work five days per week in Emeryville, California. Primary responsibilities include formulation screening, accelerated stability, forced degradation, material/device compatibility and formulation analytics. Requisites include a B.S. degree, a willingness to learn, good communication skills and a general enthusiasm for science.
MAJOR DUTIES & RESPONSIBILITIES:
- Execute high-throughput, plate-based formulation screening, including formulation preparation, stability studies, sample testing, data analysis, and documentation.
- Support prefilled-syringe and other container/device compatibility assessments.
- Formulation analytics including but not limited to Size-Exclusion Multi-Angle Light Scattering, Differential Scanning Fluorimetry, Dynamic Light Scattering, pH and osmo testing.
- Collaboration with Upstream PD, Downstream PD and AD/QC
QUALIFICATIONS:
Education:
- Bachelors of Science Degree
Experience:
- 0+ years of experience within the Biotech or similar industry
- Strong foundational laboratory skills, including accurate pipetting, solution preparation, weighing, basic laboratory calculations, and data organization using Excel.
- Hands-on laboratory experience gained through academic research, internships, or industry.
- Experience with preformulation, formulation development, stability studies, drug-product process development, or downstream process development is preferred.
- Experience with biologics, including proteins, antibodies, or AAV/gene therapy, is a plus.
Other Qualifications/Skills:
- Applicant should possess a general competency in Microsoft based applications (e.g., Word, Excel, PowerPoint)
- Prior experience with statistical tools (e.g., JMP) or Prefilled Syringe development is preferred, but not required
Travel: This role does not require travel outside of the main office. However, may provide opportunities to travel in future (e.g., to attend conferences or oversee outsourced activities)
Physical Requirements and Working Conditions:
- Physical Activity - Repetitive motions: Making substantial movements (motions) of the wrists, hands, and/or fingers. Fingering: Picking, pinching, typing or otherwise working, primarily with fingers rather than with whole hand or arm as in handling. Talking: Expressing or exchanging ideas by means of the spoken word.
- Physical Requirements - Lifting up to 20 lbs, bending, lifting, twisting, ability to wear Personal Protective Equipment such as lab coat, goggles/glasses, and nitrile gloves
- Working Conditions - The worker is not substantially exposed to adverse environmental conditions (as in typical office or administrative work).
Hourly compensation range: $39.00 - $45.00 / HOUR
Please note, the base salary compensation range and actual salary offered to the final candidate depends on various factors: candidate’s geographical location, relevant work experience, skills, and years of experience.
4DMT provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, genetic information, marital status, status as a covered veteran, and any other category protected under applicable federal, state, provincial and local laws.
Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities
4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF biologics (aflibercept and anti-VEGF-C) with a single intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration, which is currently in Phase 3 development, and second indication is diabetic macular edema. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery.
We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our Core Values drive the way we work together:
- Dare to Cure
- Break Boundaries
- Beyond Yourself
- Prepare & Execute Relentlessly
Join us in creating the future of genetic medicine.
Founded
2013
Company size
51-200 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Emeryville, California
4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF biologics (aflibercept and anti-VEGF-C) with a single intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration, which is currently in Phase 3 development, and second indication is diabetic macular edema. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery.
We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our Core Values drive the way we work together:
- Dare to Cure
- Break Boundaries
- Beyond Yourself
- Prepare & Execute Relentlessly
Join us in creating the future of genetic medicine.
Founded
2013
Company size
51-200 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Emeryville, California